BostonGene is a series b startup based in United States. 1 investor tracked on Brouky Intelligence. Data sourced from Brouky Intelligence.
About
BostonGene is a biomedical software company that has developed an AI-driven molecular and immune profiling platform to identify and validate novel targets for personalized cancer therapies.
Stage
series-b
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky